期刊文献+

猪圆环病毒Ⅱ型Cap、Rep基因原核表达质粒的构建与表达 被引量:1

Construction of Prokaryotic Expression Vector of Cap and Rep Protein of Porcine Circovirus Type Ⅱ and Expression in E.coli BL21
下载PDF
导出
摘要 为进一步建立猪圆环病毒Ⅱ型(PCVⅡ)的有效检测方法,以及制备结构蛋白Cap和非结构蛋白Rep的单克隆抗体。根据GenBank中登录的PCVⅡ序列,设计2对特异性引物,PCR扩增出Cap、Rep蛋白基因,连接到pMD18-Tsimple质粒上,测序正确的Cap和Rep基因双酶切后分别插入到pACYCDuet-1上,构建成原核表达质粒pACYCDuet-1-Cap、pACYCDuet-1-Rep和pACYCDuet-1-Rep-Cap,然后将上述原核表达质粒转化BL21(DE3),并用IPTG进行诱导表达。结果表明:成功地在大肠杆菌BL21(DE3)中表达了猪圆环病毒Ⅱ型的Cap、Rep蛋白,且Rep、Cap蛋白共表达质粒pACYCDuet-1-Cap-Rep的表达效果优于其他2种质粒。 In order to develop effective detection methods and prepare monoclonal antibody of porcine circovirus type Ⅱ, Cap and Rep genes of porcine eircovirus type Ⅱ were amplified and cloned into pMD18-Tsimple vector. And the genes were sequenced. Then Cap and Rep genes were sub-cloned into pACYCDuet-1 vector to generate three prokaryotic expression plasmids named pACYCDuet-I-Cap, pACYCDuet-1-Rep, and pACYCDuet-1-Rep -Cap. The plasmids were transformed into E.coli BL21 (DE3) and expressed. The results of Western-blotting showed that the two proteins were expressed successfully in E. eoli BL21 (DE3). Furthermore, plasmid for coexpression of two proteins expressed better than the other two plasmids.
出处 《中国农学通报》 CSCD 2012年第20期98-101,共4页 Chinese Agricultural Science Bulletin
关键词 猪圆环病毒Ⅱ型(PCVⅡ) 原核表达 Western-blotting Porcine circovirus type Ⅱ Prokaryotic expression Western-blotting
  • 相关文献

参考文献19

二级参考文献71

  • 1申会刚,周继勇,陈庆新,郭军庆,陈婷飞,商绍彬,李增魁.猪圆环病毒Ⅱ型Rep基因在PK15细胞中的表达及特性[J].中国兽医学报,2005,25(3):244-246. 被引量:7
  • 2刘长明,张超范,危艳武,谭斌,陆月华,谷守林.猪圆环病毒2型细胞培养适应毒株的培育和鉴定[J].中国预防兽医学报,2006,28(3):248-252. 被引量:26
  • 3周复春 陈焕春 等.猪伪狂犬病病毒PCR检测方法的建立[J].华中农业大学学报,2000,33:12-15.
  • 4SEGAL~S J, DOMINGO M. Postweaning multisystemic wasting syndrome(PMWS) in pigs[J]. Vet Q, 2002,24 (3) : 109- 124.
  • 5CHAE C. A review of porcine eircovirus 2-associated syndromes and diseases[J]. Vet J ,2005,169(3) :326-336.
  • 6DARWICH L, SEGAL S J, MATEU E. Pathogenesis of postweaning multisystemic wasting syndrome caused by porcine circovirus 2 : an immune riddle[J]. Arch Virol, 2004,149 (5) : 857-874.
  • 7SHANG S B,JIN Y L,JIANG X T,etal. Fine mapping of antigenie epitopes on capsid proteins of porcine circovirus, and antigenic phenotype of porcine eircovirus type 2[J]. Mol Immunol,2009,46(3):327 -334.
  • 8MAGAR R, MULLER P, LAROCHEI.LE R. Retrospective se- rological survey of antibodies to porcine cireovirus type 1 and type 2[J]. Can J Vet Res, 2000,64(3):184- 186.
  • 9NAWAGITAGUL P, HARMS P A, MOROZOV I, et al. Modified indirect porcine circovirus(PCV) type 2-based and recombinant eapsid protein (ORF2) based enzyme-linked im munosorbent assays for detection of antibodies to PCV[J]. Clin Diagn Lab lmmunol, 2002,9 (1) : 33- 40.
  • 10WALKER I W,KONOBYK C A,JEWHURST V A,et al. Development and application of a competitive enzyme-linked im munosorbent assay for the detection of serum antibodies to porcine circovirus type 2 [J]. J Vet Diagn lnvest, 2000,12 (5) : 400-405.

共引文献606

同被引文献33

  • 1Chae C. A review of porcine circovirus 2-associated syndromes and diseases [J]. Vet J , 2005 , 169(3) : 326-336.
  • 2Zhai S L , Chen S N , Xu Z H , et al. Porcine cireovirus type 2 in China: an update on and insights to its prevalence and control [J]. VirolJ , 2014 , 11 : 88.
  • 3Khayat R , Brunn N , Speir J A , et al. The 2. 3-angstrom struc-ture of porcine circovirus 2 [ Jl. J Virol, 2011, 85 (15) : 7856 -7862.
  • 4Opriessnig T , Patterson A R , Madson D M , et al. Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV-PCV2-SIV clinical infection model 2-3-months post vaccination [J]. Vaccine, 2009, 27(7): 1002-1007.
  • 5Huang L , Lu Y , Wei Y , et al. Development of a blocking ELISA for detection of serum neutralizing antibodies against porcine circovir- us type2 [J]. JVirolMethods, 2011, 171(1) : 26-33.
  • 6Seo H W, Han K, Park C, et al. Clinical, virological, immunologi- cal and pathological evaluation of four porcine circovirus type 2 vac- cines [J]. Vet J, 2014, 200(1) : 65-70.
  • 7Huang C J , Lin H , Yang X. Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements [ J]. J Ind Microbiol Biotechnol, 2012, 39(3): 383-399.
  • 8Shuai J, Zhang X, Chen W, et al. In vivo characterization of chime- ric PCV DNA clones containing heterogeneous capsid protein nuclear localization signals(NLS) EJ~. Virol J, 2013, 10: 16.
  • 9Wu P C, Lin W L, Wu C M, et al. Characterization of porcine cir- covirus type 2 ( PCV2 ) capsid particle assembly and its application to virus-like panicle vaccine development [ J ]. Appl Microbiol Bio- technol, 2012, 95(6) : 1501-1507.
  • 10Zhou J Y, Shang S B, Gong H, et al. In vitro expression, mono- elonal antibody and bioactivity for capsid protein of porcine eireovims type II without nuclear localization signal [ J]. J Bioteehnol, 2005, 118(2) : 201-211.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部